Tenecteplase in acute ischemic stroke: an updated meta-analysis
Hussain Almohammed, Ahmed Salah Morad, Bushra Wadi Bin Saddiq, Fatimah Ibrahim Almuhaysin, Bayan Mohammed Khair Al Zoabi, Wejdan Ahmed Aldawsari, Tanveer Nidal Khan, Husna Irfan Thalib, Zainab Alabdi · 2026
Read Tenecteplase in acute ischemic stroke: an updated meta-analysis by Hussain Almohammed, Ahmed Salah Morad, Bushra Wadi Bin Saddiq, Fatimah Ibrahim Almuhaysin, Bayan Mohammed Khair Al Zoabi, Wejdan Ahmed Aldawsari, Tanveer Nidal Khan, Husna Irfan Thalib, Zainab Alabdi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13619431.txt.
Description
Hussain Almohammed and co-authors pool past trials to compare two clot-busting drugs for stroke, in a review from two thousand twenty-six. One drug is tenecteplase and the other is alteplase, the long-used standard. The team searched five large databases for trials and ward studies in adults with blocked-vessel stroke.
Twenty-four studies with more than twenty thousand patients were pooled. The newer drug gave a slightly better chance of full recovery at three months and a faster start to care. Deaths were lower in ward studies but not in strict trials alone. No clear safety gap was found. Readers get a balanced view that still calls for more strict trials.
Catalog record
| CREATOR | Hussain Almohammed, Ahmed Salah Morad, Bushra Wadi Bin Saddiq, Fatimah Ibrahim Almuhaysin, Bayan Mohammed Khair Al Zoabi, Wejdan Ahmed Aldawsari, Tanveer Nidal Khan, Husna Irfan Thalib, Zainab Alabdi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 41 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |